Sinemet and Rivaroxaban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sinemet (carbidopa; levodopa) and Rivaroxaban (rivaroxaban). Common drug interactions include restlessness among females and balance disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Sinemet and Rivaroxaban. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Sinemet?

Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.

What is Rivaroxaban?

Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.



On Aug, 11, 2026

28 people who take Sinemet and Rivaroxaban together, and have interactions are studied.

Sinemet and Rivaroxaban drug interactions.

What are the common drug interactions of Sinemet and Rivaroxaban, by gender? *:

female:

  1. Restlessness (not able to rest)
  2. Scar
  3. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  4. Stoma site reaction (reaction at abdominal opening)
  5. Cerebral haemorrhage (bleeding within the brain)
  6. Hemiplegia (paralysis of one side of the body)
  7. Thalamus haemorrhage (bleeding in thalamus)
  8. Abdominal pain
  9. Aggression
  10. Confusional state

male:

  1. Balance disorder
  2. Insomnia (sleeplessness)
  3. Headache (pain in head)
  4. Injury
  5. Lethargy (tiredness)
  6. Temperature intolerance (inability to go in temperature)
  7. Abnormal dreams
  8. Aggression
  9. Anger
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the common drug interactions of Sinemet and Rivaroxaban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Balance disorder
  2. Insomnia (sleeplessness)
  3. Dizziness
  4. Headache (pain in head)
  5. Injury
  6. Lethargy (tiredness)
  7. Temperature intolerance (inability to go in temperature)
  8. Abnormal dreams
  9. Anger
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 12 people, 42.86%
  2. Arrhythmias (irregular heartbeat): 8 people, 28.57%
  3. Stable Angina (a constant chest pain): 7 people, 25.00%
  4. Quit Smoking: 7 people, 25.00%
  5. Heart Attack: 7 people, 25.00%
  6. Sleep Disorder: 5 people, 17.86%
  7. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 14.29%
  8. Hyperthyroidism (over activity of the thyroid gland): 4 people, 14.29%
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 14.29%
  10. Depression: 4 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sinemet and Rivaroxaban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sinemet and Rivaroxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rivaroxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sinemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rivaroxaban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa and rivaroxaban (the active ingredients of Sinemet and Rivaroxaban, respectively), and Sinemet and Rivaroxaban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: